Literature DB >> 19350396

Iron trafficking as an antimicrobial target.

Rosanne E Frederick1, Jeffery A Mayfield, Jennifer L DuBois.   

Abstract

Iron is essential for the survival of most organisms. Microbial iron acquisition depends on multiple, sometimes complex steps, many of which are not shared by higher eukaryotes. Depriving pathogenic microbes of iron is therefore a potential antimicrobial strategy. The following minireview briefly describes general elements in microbial iron uptake pathways and summarizes some of the current work aiming at their medicinal inhibition.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19350396      PMCID: PMC3742301          DOI: 10.1007/s10534-009-9236-1

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  71 in total

1.  Modular Peptide Synthetases Involved in Nonribosomal Peptide Synthesis.

Authors:  Mohamed A. Marahiel; Torsten Stachelhaus; Henning D. Mootz
Journal:  Chem Rev       Date:  1997-11-10       Impact factor: 60.622

Review 2.  Microbial ferric iron reductases.

Authors:  Imke Schröder; Eric Johnson; Simon de Vries
Journal:  FEMS Microbiol Rev       Date:  2003-06       Impact factor: 16.408

3.  Bacterial colonization of nasal mucosa induces expression of siderocalin, an iron-sequestering component of innate immunity.

Authors:  Aaron L Nelson; Jonathan M Barasch; Ralph M Bunte; Jeffrey N Weiser
Journal:  Cell Microbiol       Date:  2005-10       Impact factor: 3.715

4.  Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.

Authors:  Ravindranadh V Somu; Helena Boshoff; Chunhua Qiao; Eric M Bennett; Clifton E Barry; Courtney C Aldrich
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

5.  An iron delivery pathway mediated by a lipocalin.

Authors:  Jun Yang; David Goetz; Jau Yi Li; Wenge Wang; Kiyoshi Mori; Daria Setlik; Tonggong Du; Hediye Erdjument-Bromage; Paul Tempst; Roland Strong; Jonathan Barasch
Journal:  Mol Cell       Date:  2002-11       Impact factor: 17.970

6.  Structure of TonB in complex with FhuA, E. coli outer membrane receptor.

Authors:  Peter D Pawelek; Nathalie Croteau; Christopher Ng-Thow-Hing; Cezar M Khursigara; Natalia Moiseeva; Marc Allaire; James W Coulton
Journal:  Science       Date:  2006-06-02       Impact factor: 47.728

7.  Hemoglobin receptor in Leishmania is a hexokinase located in the flagellar pocket.

Authors:  Ganga Krishnamurthy; Rajagopal Vikram; Sudha B Singh; Nitin Patel; Shruti Agarwal; Gauranga Mukhopadhyay; Sandip K Basu; Amitabha Mukhopadhyay
Journal:  J Biol Chem       Date:  2004-12-03       Impact factor: 5.157

8.  The heme oxygenase(s)-phytochrome system of Pseudomonas aeruginosa.

Authors:  Rosalina Wegele; Ronja Tasler; Yuhong Zeng; Mario Rivera; Nicole Frankenberg-Dinkel
Journal:  J Biol Chem       Date:  2004-08-15       Impact factor: 5.157

9.  Isolation and biochemical characterization of two soluble iron(III) reductases from Paracoccus denitrificans.

Authors:  Jirí Mazoch; Radek Tesarík; Vojtech Sedlácek; Igor Kucera; Jaroslav Turánek
Journal:  Eur J Biochem       Date:  2004-02

10.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

View more
  15 in total

Review 1.  Are pathogenic bacteria just looking for food? Metabolism and microbial pathogenesis.

Authors:  Laurence Rohmer; Didier Hocquet; Samuel I Miller
Journal:  Trends Microbiol       Date:  2011-05-18       Impact factor: 17.079

Review 2.  An update on iron acquisition by Legionella pneumophila: new pathways for siderophore uptake and ferric iron reduction.

Authors:  Nicholas P Cianciotto
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

Review 3.  Heteroatom-Heteroatom Bond Formation in Natural Product Biosynthesis.

Authors:  Abraham J Waldman; Tai L Ng; Peng Wang; Emily P Balskus
Journal:  Chem Rev       Date:  2017-04-04       Impact factor: 60.622

4.  Non-nucleoside inhibitors of BasE, an adenylating enzyme in the siderophore biosynthetic pathway of the opportunistic pathogen Acinetobacter baumannii.

Authors:  João Neres; Curtis A Engelhart; Eric J Drake; Daniel J Wilson; Peng Fu; Helena I Boshoff; Clifton E Barry; Andrew M Gulick; Courtney C Aldrich
Journal:  J Med Chem       Date:  2013-03-13       Impact factor: 7.446

5.  Flavin oxidation in flavin-dependent N-monooxygenases.

Authors:  Reeder M Robinson; Catherine A Klancher; Pedro J Rodriguez; Pablo Sobrado
Journal:  Protein Sci       Date:  2018-09-25       Impact factor: 6.725

6.  Preparation of bifunctional isocyanate hydroxamate linkers: Synthesis of carbamate and urea tethered polyhydroxamic acid chelators.

Authors:  Rasika Fernando; Jonathan M Shirley; Emilio Torres; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2012-11-21       Impact factor: 2.415

7.  Ferritin and ferrihydrite nanoparticles as iron sources for Pseudomonas aeruginosa.

Authors:  Carolyn Dehner; Nydia Morales-Soto; Rabindra K Behera; Joshua Shrout; Elizabeth C Theil; Patricia A Maurice; Jennifer L Dubois
Journal:  J Biol Inorg Chem       Date:  2013-02-16       Impact factor: 3.358

8.  Comprehensive spectroscopic, steady state, and transient kinetic studies of a representative siderophore-associated flavin monooxygenase.

Authors:  Jeffery A Mayfield; Rosanne E Frederick; Bennett R Streit; Timothy A Wencewicz; David P Ballou; Jennifer L DuBois
Journal:  J Biol Chem       Date:  2010-07-22       Impact factor: 5.157

9.  Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.

Authors:  Timothy A Wencewicz; Timothy E Long; Ute Möllmann; Marvin J Miller
Journal:  Bioconjug Chem       Date:  2013-02-14       Impact factor: 4.774

10.  Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target.

Authors:  Cedric P Owens; Nicholas Chim; Celia W Goulding
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.